WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

This group comprises all hormonal preparations for systemic use, except:
- Insulins, see A10.
- Anabolic steroids, see A14.
- Catecholamines, see C01C and R03C.
- Sex hormones, see G03.
- Sex hormones used in treatment of neoplastic diseases, see L02.
- Metreleptin used for treatment of complications of leptin deficiency in patients with generalised lipodystrophy is classified in A16AA.

The DDDs are generally based on the treatment or diagnosis of endocrine disorders.


H04 PANCREATIC HORMONES
H04A GLYCOGENOLYTIC HORMONES
H04AA Glycogenolytic hormones

The pancreas glycogenolytic hormone glucagon is classified in this group.
Diazoxide, which is also used for treatment of hypoglycemia, is classified in C02DA01 and V03AH01.
Insulins are classified in A10A.

The DDD of glucagon is based on single dose treatment of hypoglycemia.


    ATC code  Name  DDD  U Adm.R Note
    H04AA01 glucagon mg 
    mg 

List of abbreviations

Last updated: 2024-01-26